期刊文献+

丙戊酸钠对Kasumi-1细胞周期蛋白及周期蛋白依赖性激酶抑制剂的影响 被引量:2

The study of influence on cyclin and cyclin-dependent kinase inhibitor of Kasumi-1 cell treated with VPA
原文传递
导出
摘要 目的探讨组蛋白脱乙酰化酶(HDAC)抑制剂丙戊酸钠(VPA)对t(8;21)/AML细胞株Kasumi-1细胞周期蛋白及其周期蛋白依赖性激酶抑制剂基因的影响。方法将Kasumi-1细胞经不同浓度VPA处理不同时间,应用反转录聚合酶链反应(RT—PCR)技术检测细胞周期调节因子mRNA水平的变化。结果VPA下调cyclinD1、cyclinE1及cyclinB1 mRNA水平,上调p21^WAF1/CIP1 mRNA表达,对p27^KIP1 mRNA表达无明显影响。结论VPA可通过对Kasumi-1细胞周期蛋白及周期蛋白依赖性激酶抑制剂的影响调节细胞周期,使细胞阻滞于G0/G1期。 Objective To explore the influence on cyclin and cyclin-dependent kinase inhibitor of cell cycle of Kasumi-1 cell-derived from t(8;21)/AML treated with histone deacetylase (HDAC)inhibitor valproic acid(VPA). Methods RT-PCR assay was applied to detect mRNA expression of regulation factor of cell cycle of Kasumi-1 cell with VPA at different concentration and different time. Results VPA could down-regulate mRNA expression of cyclinD1, cyclinE1 and cyclinB1, and up-regulate mRNA expression of p21^WAF1/CIP1 with no obvious variation of mRNA level of p27^KIP1. Conclusion VPA could regulate cell cycle through the regulation of cyclins and cyclin-dependent kinase,arresting Kasumi-1 cell at G0/G1 phase.
出处 《白血病.淋巴瘤》 CAS 2009年第1期5-8,共4页 Journal of Leukemia & Lymphoma
基金 河北省自然科学基金(C2008000660)
关键词 白血病 急性 细胞周期蛋白类 细胞周期蛋白依赖激酶抑制剂 Kasumi-1细胞株 Leukemia, acute Cyclins Cyclin-dependent kinase inhibitor Kasumi-1 cell line
  • 相关文献

参考文献2

二级参考文献37

  • 1Rahmani M, Yu C, Reese E, et al. Inhibition of PI - 3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21 (CIP1/WAF1) induction rather than AKT inhibition[
  • 2Klisvic M I, Maghraby E A, Parthun M R, et al. Depsipeptide (FR901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1-ETO-positive leukemic cells [J]. Leukemia, 2003, 17
  • 3Rosato R R, Almenara J A, Cartee L, et al.The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAFI/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells[J]. Mol Cancer Ther, 200
  • 4Aron J L, Parthun M R, Marcucci G, et al. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase-8-mediated apotosis and downregulation of c-FLI
  • 5Lavelle D, Chen Y H, Hankewych M, et al. Histonc deacetylase inhibitors increase p21 (WAF1) and induce apoptosis of human myeloma cell lines in dependent of decreased IL-6 receptor expression[J]. Am J Hematol, 2001, 68:170-178.
  • 6Rosato R R, Almenara J A, Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF11 [J]. Cancer Res,
  • 7Ruefli A A, Ausserlechner M J, Bernhard D, et al. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species [
  • 8Jenuwein T, AIlis C D. Translating the histone code[J]. Science, 2001, 293:1074-1080.
  • 9Marks P A, Rifkind R A, Richon V M, et al. Histone deacetyiase and cancer: causes and therapies[J]. Nature, 2001, 1:194-202.
  • 10Finnin M S, Donigian J R, Cohen A, et al. Structures of a histone deaostylase homologue bound to TSA and SAHA[J]. Nature, 1999, 401:188-193.

共引文献8

同被引文献19

  • 1邵淑丽,赵瑞霞,王丽霞,王全红,赵旭晔.宫颈癌新辅助化疗的临床价值及化疗后CyclinD_1和nm23H_1的表达[J].肿瘤研究与临床,2006,18(5):317-318. 被引量:3
  • 2李蓓,张磊,王卉,郝静,扈东艳,李明,王秀问.NSCLC细胞周期素D1和p27异常表达与化疗敏感性及预后的相关性研究[J].山东大学学报(医学版),2006,44(9):963-966. 被引量:3
  • 3Hayward JL, Rubens RD. Assessment of response to therapy in advanced breast cancer. Br J Cancer, 1977, 35: 292-298.
  • 4Ormandy CJ, Musgrove EA, Hui R, et al. CyclinD1,EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat, 2003, 78: 323-335.
  • 5桑建新,王永潮,周清源.利用原位杂交分析几种和CDK基因在人乳腺癌中的异常表达.解剖学,1999,30:224-226.
  • 6何侠,叶艳丽,林忠宁,等.鼻咽癌移植瘤eyclinD1表达和化疗相关性.癌症,2003,22:86-90.
  • 7SHAPIRO G I. Cyclin-dependent kinase pathways as targets for cancer treatment[J].{H}Journal of Clinical Oncology,2006,(11):1770-1783.
  • 8LEE Y M,SICINSKI P. Targeting cyclins and cyclin-dependent kinases in cancer:lessons from mice,hopes for therapeutic applications in humans[J].{H}CELL CYCLE,2006,(18):2110-2114.
  • 9OGINO S,NOSHO K,SHIMA K. p21 Expression in colon cancer and modifying effects of patient age and body mass index on prognosis[J].{H}Cancer Epidemiology Biomarkers & Prevention,2009,(09):2513-2521.
  • 10JOHNSON G G,SHERRINGTON P D,CARTER A. A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 gene[J].{H}CANCER RESEARCH,2009,(12):5210-5217.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部